1. Home
  2. EAT vs HALO Comparison

EAT vs HALO Comparison

Compare EAT & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinker International Inc.

EAT

Brinker International Inc.

HOLD

Current Price

$177.39

Market Cap

7.2B

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$78.55

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EAT
HALO
Founded
1975
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.1B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
EAT
HALO
Price
$177.39
$78.55
Analyst Decision
Buy
Buy
Analyst Count
21
11
Target Price
$183.00
$78.64
AVG Volume (30 Days)
909.3K
1.7M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
144.71
N/A
EPS
7.90
1.22
Revenue
$5,384,200,000.00
$151,862,000.00
Revenue This Year
$9.00
$28.24
Revenue Next Year
$5.49
$12.56
P/E Ratio
$22.49
$65.12
Revenue Growth
21.95
N/A
52 Week Low
$100.30
$54.21
52 Week High
$178.25
$82.22

Technical Indicators

Market Signals
Indicator
EAT
HALO
Relative Strength Index (RSI) 70.06 72.47
Support Level $128.82 $67.12
Resistance Level N/A $79.50
Average True Range (ATR) 6.85 2.42
MACD 1.13 0.89
Stochastic Oscillator 97.99 99.52

Price Performance

Historical Comparison
EAT
HALO

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: